ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

RICHARD APAU MD

730 SE OAK STREET SUITE G CASCADE INTERNAL MEDICINE

Hillsboro | Oregon | 97123

(503) 693-1300

Incorrect Info?
Search this name in Dollars for Docs »
See this provider's services »

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,762Medicare Part D Prescriptions Filled, Including Refills

Rank: 203 out of 761

$350K Total Retail Price of All Prescriptions

Rank: 260 out of 761

334 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
20% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 334 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

20% of this provider’s 334 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

3% of this provider’s 6,586 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
LISINOPRIL 413 355 1 1
LEVOTHYROXINE SODIUM 310 285 2 3
HYDROCODONE-ACETAMINOPHEN 266 216 S3 3 5
HYDROCHLOROTHIAZIDE 248 226 4 11
ZOLPIDEM TARTRATE 191 176 5 22
ATORVASTATIN CALCIUM 182 168 6 12
OMEPRAZOLE 181 152 7 4
WARFARIN SODIUM 173 169 8 9
GABAPENTIN 173 134 8 15
METFORMIN HCL 169 139 10 10
LOVASTATIN 168 125 11 17
AMLODIPINE BESYLATE 165 155 12 6
ATENOLOL 155 134 13 8
CITALOPRAM HBR 140 136 14 19
LOSARTAN POTASSIUM 138 127 15 13
OXYCODONE HCL 126 100 S2 16 24
SIMVASTATIN 118 117 17 2
FUROSEMIDE 114 111 18 7
METOPROLOL TARTRATE 106 92 19 14
ALENDRONATE SODIUM 79 74 20 21
SERTRALINE HCL 72 61 21 25
ALLOPURINOL 71 48 22 28
CLOPIDOGREL 68 59 23 66
CYCLOBENZAPRINE HCL 67 57 R 24 51
METOPROLOL SUCCINATE 66 54 25 16
GLIMEPIRIDE 65 64 26 48
BACLOFEN 62 44 27 120
CARISOPRODOL 62 32 R 27 131
DONEPEZIL HCL 62 62 27 33
TRAMADOL HCL 61 54 30 34
PROAIR HFA 58 17 31 32
MORPHINE SULFATE ER 58 44 S2 31 38
PANTOPRAZOLE SODIUM 57 44 33 40
FLUOXETINE HCL 57 38 33 31
CIPROFLOXACIN HCL 55 52 35 63
VERAPAMIL ER 54 30 36 109
ADVAIR DISKUS 53 49 37 37
POTASSIUM CHLORIDE 52 50 38 18
LANTUS 50 50 39 41
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.